Cargando…
Review of the Agnostic-Type Treatment Approach: Treating Cancer by Mutations, Not by Location
Recent years has seen the discovery and description of genetic alterations responsible for oncogenesis in a wide variety of cancers, together with the finding that some markers are actionable and can be targeted by medications. Such developments have enabled cancer treatments to evolve from empirica...
Autores principales: | Rosas, Daniel, Raez, Luis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359975/ https://www.ncbi.nlm.nih.gov/pubmed/32700078 http://dx.doi.org/10.1007/s40487-020-00114-4 |
Ejemplares similares
-
Gene-agnostic approaches to treating inherited retinal degenerations
por: Chew, Lindsey A., et al.
Publicado: (2023) -
Neuregulin 1 Gene (NRG1). A Potentially New Targetable Alteration for the Treatment of Lung Cancer
por: Rosas, Daniel, et al.
Publicado: (2021) -
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature
por: Bernocchi, Ottavia, et al.
Publicado: (2021) -
Molecular-Targeted Therapy for Tumor-Agnostic Mutations in Acute Myeloid Leukemia
por: Arai, Hironori, et al.
Publicado: (2022) -
Precision medicine becomes reality—tumor type-agnostic therapy
por: Yan, Li, et al.
Publicado: (2018)